Skip Nav Destination
Issues
15 October 2008
-
Cover Image
Cover Image
Confocal laser scanning microscope image showing accumulation of the fluorescence-labeled (green) immunotoxin scFv(14E1)-ETA (directed against the epidermal growth factor receptor) in cisplatin-resistant neuroblastoma cells (red). For further details, please see Michaelis and coworkers on page 6531 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
CCR Biostatistics
Molecular Pathways
Reviews
Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
Robert E. Coleman; Theresa A. Guise; Allan Lipton; G. David Roodman; James R. Berenson; Jean-Jacques Body; Brendan F. Boyce; Laura M. Calvi; Peyman Hadji; Eugene V. McCloskey; Fred Saad; Matthew R. Smith; Larry J. Suva; Russell S. Taichman; Robert L. Vessella; Katherine N. Weilbaecher
Human Cancer Biology
The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation
John A. Conti; Timothy J. Kendall; Adrian Bateman; Thomas A. Armstrong; Andrew Papa-Adams; Qian Xu; Graham Packham; John N. Primrose; R. Christopher Benyon; John P. Iredale
Cancer Therapy: Preclinical
A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor
Paul A. Foster; Surinder K. Chander; Simon P. Newman; L.W. Lawrence Woo; Oliver B. Sutcliffe; Christian Bubert; Dujin Zhou; Shiuan Chen; Barry V.L. Potter; Michael J. Reed; Atul Purohit
Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin
Geoffrey D. Girnun; Liang Chen; Jessica Silvaggi; Ronny Drapkin; Lucian R. Chirieac; Robert F. Padera; Rabi Upadhyay; Scott B. Vafai; Ralph Weissleder; Umar Mahmood; Elnaz Naseri; Stephanie Buckley; Danan Li; Jeremy Force; Kate McNamara; George Demetri; Bruce M. Spiegelman; Kwok-Kin Wong
Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers
Katsunori Imai; Shinya Hirata; Atsushi Irie; Satoru Senju; Yoshiaki Ikuta; Kazunori Yokomine; Michiko Harao; Mitsuhiro Inoue; Takuya Tsunoda; Shuichi Nakatsuru; Hidewaki Nakagawa; Yusuke Nakamura; Hideo Baba; Yasuharu Nishimura
Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine Model
Laleh G. Melstrom; David J. Bentrem; Mohammad R. Salabat; Timothy J. Kennedy; Xian-Zhong Ding; Matthew Strouch; Sambasiva M. Rao; Richard C. Witt; Charles A. Ternent; Mark S. Talamonti; Richard H. Bell; Thomas A. Adrian
Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
Martin Michaelis; Jennifer Bliss; Sonja C. Arnold; Nora Hinsch; Florian Rothweiler; Hedwig E. Deubzer; Olaf Witt; Klaus Langer; Hans W. Doerr; Winfried S. Wels; Jindrich Cinatl, Jr.
Imaging, Diagnosis, Prognosis
Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Mei-Lin W. Ah-See; Andreas Makris; N. Jane Taylor; Mark Harrison; Paul I. Richman; Russell J. Burcombe; J. James Stirling; James A. d'Arcy; David J. Collins; Michael R. Pittam; Duraisamy Ravichandran; Anwar R. Padhani
Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
Lucy R. Webster; Shu-Fen Lee; Clare Ringland; Adrienne L. Morey; Andrew M. Hanby; Graeme Morgan; Karen Byth; Patricia A. Mote; Pamela J. Provan; Ian O. Ellis; Andrew R. Green; Gillian Lamoury; Peter Ravdin; Christine L. Clarke; Robyn L. Ward; Rosemary L. Balleine; Nicholas J. Hawkins
Cancer Therapy: Clinical
Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
Johann S. de Bono; Rebecca Kristeleit; Anthony Tolcher; Peter Fong; Simon Pacey; Vasilios Karavasilis; Monica Mita; Heather Shaw; Paul Workman; Stan Kaye; Eric K. Rowinsky; Wynne Aherne; Peter Atadja; Jeffrey W. Scott; Amita Patnaik
IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis
Minoru Isomura; Natsuo Oya; Seiji Tachiiri; Yuko Kaneyasu; Yasumasa Nishimura; Tetsuo Akimoto; Masato Hareyama; Tadasi Sugita; Norio Mitsuhashi; Takashi Yamashita; Masahiko Aoki; Heitetsu Sai; Yutaka Hirokawa; Koh-ichi Sakata; Kumiko Karasawa; Akihiro Tomida; Takashi Tsuruo; Yoshio Miki; Tetsuo Noda; Masahiro Hiraoka
Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
Allan Lipton; Guenther G. Steger; Jazmin Figueroa; Cristina Alvarado; Philippe Solal-Celigny; Jean Jacques Body; Richard de Boer; Rossana Berardi; Pere Gascon; Katia S. Tonkin; Robert E. Coleman; Alexander H.G. Paterson; Guozhi M. Gao; Amy C. Kinsey; Mark C. Peterson; Susie Jun
A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
Emilian Racila; Brian K. Link; Wen-Kai Weng; Thomas E. Witzig; Stephen Ansell; Matthew J. Maurer; Jian Huang; Christopher Dahle; Ahmad Halwani; Ronald Levy; George J. Weiner
A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
Archie N. Tse; David S. Klimstra; Mithat Gonen; Manish Shah; Tahir Sheikh; Rachel Sikorski; Richard Carvajal; Janet Mui; Caroll Tipian; Eileen O'Reilly; Ki Chung; Robert Maki; Robert Lefkowitz; Karen Brown; Katia Manova-Todorova; Nian Wu; Merrill J. Egorin; David Kelsen; Gary K. Schwartz
Cancer Prevention and Susceptibility
JC Virus Infection in Colorectal Neoplasia That Develops after Liver Transplantation
Michael Selgrad; Jan Jacob Koornstra; Lucia Fini; Marloes Blom; Rong Huang; Edward B. DeVol; Wytske Boersma-van Ek; Gerard Dijkstra; Robert C. Verdonk; Steven de Jong; Ajay Goel; Sharenda L. Williams; Richard L. Meyer; Elizabeth B. Haagsma; Luigi Ricciardiello; C. Richard Boland
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.